Murine Myelin Basic Protein C1 Isoform, 1-105 (MBP - DC-rmMBP) |
Source: murine protein overexpressed in E. coli BL21(DE3)-RIP. Purity: >90… |
0.5mg |
EGP003 |
More Info
|
Murine Myelin Basic Protein C1 Isoform (MBP - rmMBP-C1) |
Source: murine protein overexpressed in E. coli BL21(DE3)-RIP. Purity: >90… |
0.5mg |
EGP004 |
More Info
|
Murine Myelin Basic Protein C1 Isoform (MBP - S17C,T92,95E-UTC1) |
Source: murine protein overexpressed in E. coli BL21(DE3)-RIP. Purity: >90… |
0.5mg |
EGP006 |
More Info
|
Murine Myelin Basic Protein C1 Isoform (MBP - S17C,T95E-UTC1) |
Source: murine protein overexpressed in E. coli BL21(DE3)-RIP. Purity: >90… |
0.5mg |
EGP007 |
More Info
|
Murine Myelin Basic Protein C1 Isoform (MBP - UTC1) |
Source: murine protein overexpressed in E. coli BL21(DE3)-RIP. Purity: >90… |
0.5mg |
EGP009 |
More Info
|
Murine Myelin Basic Protein, S133-S159, Calmodulin Binding Domain (MBP a3- peptide) |
Source: SUMO-fused murine peptide overexpressed in E. coli BL21(DE3)-RIP.… |
0.5mg |
EGP012 |
More Info
|
Murine Osteoblast to Osteocyte-like Cell Line MLO-A5 |
Cell type: Postosteoblast / preosteocyte. |
1 vial |
EKC003 |
More Info
|
Murine Osteocyte-like Cell Line MLO-Y4 |
Source: Mouse (female). Cell type: Osteocyte. |
1 vial |
EKC002 |
More Info
|
Murine Squamous Cell Carcinoma Cell Line (NOOC1) |
Source: Oral squamous cell carcinoma lesions. Cell type: Squamous cells (s… |
1 vial |
EMU061 |
More Info
|
MYD88 KO (C57/129J) Macrophage Cell Line |
Source: Mouse Bone Marrow. Cell type: Macrophage. |
1 vial |
ENH179-FP |
More Info
|
Nanodiamond Based DNA Delivery Reagent |
n/a |
50ug |
ESA002 |
More Info
|
NAPhAz-1 |
Purity: >95%, HPLC. MW: 407.1594 g / mol |
1mg |
EST001 |
More Info
|
NAPhAz-1 |
Purity: >95%, HPLC. MW: 407.1594 g / mol |
5mg |
EST002 |
More Info
|
NAPhAz-1 |
Purity: >95%, HPLC. MW: 407.1594 g / mol |
10mg |
EST003 |
More Info
|
Natural Killer Cell Line (KIL) |
Source: Mouse Bone marrow culture. Cell type: Natural killer cell. |
1 vial |
EUH001 |
More Info
|
Neuro-2a Split Superfolder GFP-Tau Cell Line (N2a-ssGT) |
Source: Brain. Cell type: Neuroblast, adherent. |
1 vial |
ESF001 |
More Info
|
Neuroblastoma Cell Line (NLF-TrkA, NTA#2)) |
Source: Human Neuroblastoma. Cell type: Epithelial. |
1 vial |
ECP009 |
More Info
|
Neuroblastoma Cell Line (NLF-TrkB, NTA#6)) |
Source: Human Neuroblastoma. Cell type: Epithelial. |
1 vial |
ECP010 |
More Info
|
Neuroblastoma Cell Line (NLF-Trk-NULL) |
Source: Human Neuroblastoma. Cell type: Epithelial. |
1 vial |
ECP008 |
More Info
|
Neutrophil Specific, PET Imaging Agent |
Purity: 95%. MW: ~4.4 kDa |
200ug |
EG0046 |
More Info
|
New Zealand White Rabbit Pre-immune Serum |
n/a |
100ug (2.2mg/mL) |
EVA008 |
More Info
|
New Zealand White Rabbit Pre-immune Serum |
n/a |
100uL (0.36mg/mL) |
EVA007 |
More Info
|
New Zealand White Rabbit Pre-immune Serum (Negative Control) |
n/a |
75uL |
EOR003 |
More Info
|
NFKB p50 KO (C57/129) Macrophage Cell Line |
Source: Mouse Bone Marrow. Cell type: Macrophage. |
1 vial |
ENH180-FP |
More Info
|
NHP-Butane |
Purity: >95%, 31P NMR. MW: 298 |
100mg |
ELV001 |
More Info
|
NHP-Thiourea |
Purity: >95%, 31P NMR. MW: 436 |
100mg |
ELV002 |
More Info
|
NIH 2/4 Cell Line |
Source: mouse embryo (NIH3T3 cells). Cell type: NIH3T3 mouse embryonic fib… |
1 vial |
ENH101-FP |
More Info
|
NIH 3T3 Duo-BFP53BP1 Cell Line |
Source: mouse embryo (NIH3T3 cells). Cell type: NIH3T3 mouse embryonic fib… |
1 vial |
ENH104-FP |
More Info
|
NIH 3T3 Duo Cell Line |
Source: mouse embryo (NIH3T3 cells). Cell type: NIH3T3 mouse embryonic fib… |
1 vial |
ENH102-FP |
More Info
|
NIH 3T3 Duo-Parental Cell Line |
Source: mouse embryo (NIH3T3 cells). Cell type: NIH3T3 mouse embryonic fib… |
1 vial |
ENH103-FP |
More Info
|
NO2-Alkyne |
Purity: >98%, HPLC. MW: 283.3 |
10mg |
EST029 |
More Info
|
NO2-Alkyne |
Purity: >98%, HPLC. MW: 283.3 |
25mg |
EST030 |
More Info
|
NO2-Alkyne |
Purity: >98%, HPLC. MW: 283.3 |
50mg |
EST031 |
More Info
|
NO2-Alkyne |
Purity: >98%, HPLC. MW: 283.3 |
100mg |
EST032 |
More Info
|
NO-Bio Sulfinic Acid Probe |
Purity: >90%, HPLC. MW: 843.01 |
0.5mg |
EST011 |
More Info
|
NO-Bio Sulfinic Acid Probe |
Purity: >90%, HPLC. MW: 843.01 |
1mg |
EST012 |
More Info
|
NO-Bio Sulfinic Acid Probe |
Purity: >90%, HPLC. MW: 843.01 |
5mg |
EST013 |
More Info
|
Non-Natural Promoter T7 Polymerase |
Source: Escherichia coli. Purity: > 98% (SDS-PAGE). MW: 100.142 kDa |
100ug (40 reactions) |
EUT001 |
More Info
|
Nonspecific DNA/RNA Nuclease |
Source: E. coli. Purity: >95%. MW: 27,444 Da |
5mg (5mg/mL) |
EVC010 |
More Info
|
Norbelladine 4'-O-Methyltransferase (NpN4OMT) |
Source: E. coli BL21 (Rosetta). MW: 27,274 Da |
350ug |
EDD008 |
More Info
|
Norbornene-PEG-Biotin (Norb-Bio) Probe |
MW: 494.65 g / mol |
10mg |
EFL008 |
More Info
|
Noroxomaritidine reductase (NNR) |
Source: E. coli BL21 (Rosetta). MW: 27,724 Da |
350ug |
EDD009 |
More Info
|
NSCLC Patient Derived Xenograft (ADOR) |
Source: Human Lung. Cell type: NSCLC, adenocarcinoma. |
1 vial (1M cells) |
EVC004 |
More Info
|
ODIBO-EG4-NHS |
Purity: >99% 1HNMR. MW: 594.66 |
40mg (40mg/2mL in DMSO) |
EGA259 |
More Info
|
Oral Epithelial HIV Cell Line |
Source: Human Gingival Tissue. Cell type: Oral Epithelial Cells. |
1 vial |
ECW001-FP |
More Info
|
PA D512K (Anthrax Protective Mutant Antigen (PA-D512K)) |
Purified by: Hydroxyapatite Chromatography. |
100ug (1.84mg/mL) |
ENH011-LT |
More Info
|
PA F427A (Anthrax Protective Mutant Antigen (PA F427A)) |
Purified by: Hydroxyapatite Chromatography. |
100ug (2.23mg/mL) |
ENH007-LT |
More Info
|
PA K563C (Anthrax Protective Mutant Antigen (PA-K563C)) |
Purified by: Hydroxyapatite Chromatography. |
100ug (4.68mg/mL) |
ENH008-LT |
More Info
|
PA L687A (Anthrax Protective Mutant Antigen (PA-L687A)) |
Purified by: Q-Sepharose Ion Exchange Chromatography. |
100ug (6.24mg/mL) |
ENH009-LT |
More Info
|
PA-3M (Anthrax Protective Mutant Antigen (PA-3M)) |
Purified by: Hydroxyapatite Chromatography. |
100ug (4.86mg/mL) |
ENH004-LT |
More Info
|
PA-3M Cys (Anthrax Protective Mutant Antigen (PA-3M Cys)) |
Purified by: Hydroxyapatite Chromatography. |
100ug (2.4mg/mL) |
ENH005-LT |
More Info
|
PA-3M-SoSi-H6 (Anthrax Protective Mutant Antigen (PA-3M-SoSi-H6)) |
Purified by: Hydroxyapatite Chromatography. |
100ug (8.08mg/mL) |
ENH012-LT |
More Info
|
PA-U7 (Anthrax Protective Mutant Antigen (PA-U7)) |
Purified by: S200 Size Exclusion Chromatography. |
100ug (7.47mg/mL) |
ENH006-LT |
More Info
|
PA-U7-K562C (Anthrax Protective Mutant Antigen (PA-U7-K562C)) |
Purified by: Hydroxyapatite Chromatography. |
100ug (3.27mg/mL) |
ENH010-LT |
More Info
|
PGC-1α Expressing HEK-293T/17 Cell Line (293T-PGC) |
Source: Human Embryonic kidney. Cell type: HEK 293T / 17 (ATCC #CRL-11268). |
1 vial |
ENH069-FP |
More Info
|
Photoactivatable Serotonin (BHQ-O-5HT) |
Purity: >95%, HPLC. MW: 574.11 |
3mg |
EGA012 |
More Info
|
Photo-BAPTA, Tetramethyl Ester |
Purity: >98% 1HNMR. MW: 674.69 |
25mg |
EGA257 |
More Info
|
Photocleavable Alpha-Factor for Yeast |
Synthetic. Purity: >90%. LC / MS. MW: MW = 1799.96 g / mol, FW (TFA salt)… |
200uL (1mM) |
EPD001 |
More Info
|
Photo-DIBO-EG4-SH |
Purity: >98% 1HNMR. MW: 512.66 |
40mg (20mg/mL in DMSO) |
EGA260 |
More Info
|
Photo-ODIBO-EG4-NHS |
Purity: >99% 1HNMR. MW: 623.65 |
25mg |
EGA258 |
More Info
|
p-Hydroxybenzoic Acid (bio-derived) |
Purity: >98%, HPLC. MW: 138.12 g / mol |
1g |
ESP002 |
More Info
|
p-Hydroxybenzoic Acid (bio-derived) |
Purity: >98%, HPLC. MW: 138.12 g / mol |
5g |
ESP003 |
More Info
|
PKR KO (C57) Macrophage Cell Line |
Source: Mouse Bone Marrow. Cell type: Macrophage. |
1 vial |
ENH181-FP |
More Info
|
PMS-2 Null/Lambda-LIZ Transgene Transformed MEF Cell Line (127TAg) |
Source: Mouse embryo. Cell type: Transformed MEF. |
1 vial |
ENH118-FP |
More Info
|
Poly(1,8-carbazole)-benzothiadiazole copolymer (PCzBT) Nanoparticles |
n/a |
1mL |
EKA002 |
More Info
|
Poly(1,8-carbazole)-dithienylbenzothiadiazole copolymer (PCzDTBT) Nanoparticles |
n/a |
1mL |
EKA003 |
More Info
|
Poly(dithiazolfluorene-alt-thiadiazolobenzotriazole) (PSN) Nanoparticles |
n/a |
1mL |
EKA001 |
More Info
|
poly(GMA-ran-OEGMA) |
MW: 2.5x10^6 g / mol |
100mg |
EGA697 |
More Info
|
poly(GMA-ran-OEGMA)-Lysozyme Conjugate |
n/a |
50ug |
EGA698 |
More Info
|
Polyphosphate, Long Chain (p700) |
Purity: <1% monophosphate. MW: Heterogeneous; Number average ~113 kDa; Ran… |
100mg |
EUI002 |
More Info
|
Polyphosphate, Long Chain (p700) |
Purity: <1% monophosphate. MW: Heterogeneous; Number average ~113 kDa; Ran… |
200mg (2 x 100mg) |
EUI003 |
More Info
|
Polyphosphate, Long Chain (p700) |
Purity: <1% monophosphate. MW: Heterogeneous; Number average ~113 kDa; Ran… |
500mg (5 x 100mg) |
EUI004 |
More Info
|
Polyphosphate, Medium Chain (p100) |
Purity: <1% monophosphate. MW: Heterogeneous; Number average ~11.5 kDa; Ra… |
100mg |
EUI005 |
More Info
|
Pre-Formed Fibrils, A53T α-Synuclein (α-syn-A53T PFFs) |
Source: Human, expressed in E. coli BL21 (DE3) CP+. Purity: >95 %, purifie… |
1mg |
EGP014 |
More Info
|
Pre-Formed Fibrils, E46K α-Synuclein (α-syn-E46K PFFs) |
Source: Human, expressed in E. coli BL21 (DE3) CP+. Purity: >95 %, purifie… |
1mg |
EGP016 |
More Info
|
Pre-Formed Fibrils, WT α-Synuclein (α-syn-WT PFFs) |
Source: Human, expressed in E. coli BL21 (DE3) CP+. Purity: >95 %, purifie… |
1mg |
EGP018 |
More Info
|
Prostate Cancer Cell Line (CWR-R1-AD1) |
Source: Human Prostate. Cell type: Prostate Cancer. |
1 vial |
EMN024-FP |
More Info
|
Prostate Cancer Cell Line (CWR-R1-D567) |
Source: Human Prostate. Cell type: Prostate Cancer. |
1 vial |
EMN028-FP |
More Info
|
Prostate Cancer Cell Line (CWR-R1-I567) |
Source: Human Prostate. Cell type: Prostate Cancer. |
1 vial |
EMN029-FP |
More Info
|
Prostate Cancer Cell Line (22Rv1-undup1) |
Source: Human Prostate. Cell type: Prostate Cancer. |
1 vial |
EMN025-FP |
More Info
|
Prostate Cancer Cell Line (22Rv1-undup2) |
Source: Human Prostate. Cell type: Prostate Cancer. |
1 vial |
EMN026-FP |
More Info
|
Prostate Cancer Cell Line (22Rv1-undup3) |
Source: Human Prostate. Cell type: Prostate Cancer. |
1 vial |
EMN027-FP |
More Info
|
Pseudotyped Δ-G/CHIKV-E-NLucP rVSV |
n/a |
0.5mL (≥ 10^6 IU/mL) |
EGA316-PM |
More Info
|
Pseudotyped ΔG-DsRed (G*ΔG-DsRed) rVSV |
n/a |
300uL |
EH1018-PM |
More Info
|
Pseudotyped ΔG-DsRed (G*ΔG-DsRed) rVSV w/ pCAGGS-G-Kan |
n/a |
300uL; w/ pCAGGS-G-Kan |
EH1023-PM |
More Info
|
Pseudotyped Δ-G/EBOV-GP-NLucP rVSV |
n/a |
0.5mL (≥ 10^6 IU/mL) |
EGA297-PM |
More Info
|
Pseudotyped ΔG-GFP (G*ΔG-GFP) rVSV |
n/a |
300uL |
EH1019-PM |
More Info
|
Pseudotyped ΔG-GFP (G*ΔG-GFP) rVSVw/ pCAGGS-G-Kan |
n/a |
300uL; w/ pCAGGS-G-Kan |
EH1024-PM |
More Info
|
Pseudotyped Δ-G/LASV-GP-NLucP rVSV |
n/a |
0.5mL (≥ 10^6 IU/mL) |
EGA299-PM |
More Info
|
Pseudotyped ΔG-luciferase (G*ΔG-luciferase) rVSV |
n/a |
300uL |
EH1020-PM |
More Info
|
Pseudotyped ΔG-luciferase (G*ΔG-luciferase) rVSVw/ pCAGGS-G-Kan |
n/a |
300uL; w/ pCAGGS-G-Kan |
EH1025-PM |
More Info
|
Pseudotyped Δ-G/SARS-CoV-2-S_D614Gd21-NLucP rVSV |
n/a |
0.5mL (≥ 10^6 IU/mL) |
EGA298-PM |
More Info
|
Pseudotyped ΔG-SEAP (G*ΔG-SEAP) rVSV |
n/a |
300uL |
EH1035-PM |
More Info
|
Pseudotyped ΔG-SEAP (G*ΔG-SEAP) rVSV w/ pCAGGS-G-Kan |
n/a |
300uL; w/ pCAGGS-G-Kan |
EH1036-PM |
More Info
|
Pseudotyped Δ-G/VSV-G-NLucP rVSV |
n/a |
0.8mL (≥ 10^7 IU/mL) |
EGA317-PM |
More Info
|
P2Y1 Expressing Human Astrocytoma Cell Line (1321N1-HA-P2Y1) |
Source: Human Glial Cell. Cell type: Glioblastoma. |
1 vial |
ENC018 |
More Info
|
P2Y11 Expressing Human Astrocytoma Cell Line (1321N1-HA-P2Y11) |
Source: Human Glia Cell. Cell type: Glioblastoma. |
1 vial |
ENC022 |
More Info
|
P2Y12 Expressing Human Astrocytoma Cell Line (1321N1-HA-P2Y12) |
Source: Human Glia Cell. Cell type: Glioblastoma. |
1 vial |
ENC023 |
More Info
|
P2Y4 Expressing Human Astrocytoma Cell Line (1321N1-HA-P2Y4) |
Source: Human Glia Cell. Cell type: Glioblastoma. |
1 vial |
ENC020 |
More Info
|
Quinic Acid |
Purity: >97% 1H NMR. MW: 192.17 g / mol |
1g |
ESP005 |
More Info
|